INTRODUCTION
Anaplastic thyroid cancer (ATC) is a very rare disease with a poor prognosis [1] [2] [3] [4] [5] [6] [7] . The incidence of ATC is 1.6% according to the Surveillance, Epidemiology, and End Results (SEER) database, but it accounts for 14 to 39% of thyroid cancer deaths [7, 8] . Although results concerning survival have been variable, the mean survival time after initial diagnosis is generally considered to be 6 months [1, 9] . At initial diagnosis, cervical lymph node metastasis is commonly present, and distant metastasis is found in ＞50% of patients [10] [11] [12] .
Even with the rarity of ATC, many prognostic factors have been reported. Reporting their clinical experiences in thesurgery.or.kr One patient presented with a palpable neck mass, voice change, and mild dyspnea. In one patient, the size of the lesion was not assessable due to the removal in several pieces. [1] found that young age at initial diagnosis and locally confined disease were associated with better prognosis. A review article found that better prognosis was associated with female sex, lesion size ＜6 cm, patient age ＜60 years, less extensive disease, and no distant metastases at initial presentation [10] .
Multidisciplinary treatment and presence of intrathyroidal disease were also associated with better prognosis [7, 13] . Because of the rarity of the disease, the treatment modalities applied in these reports were varied. Thyroid Values are presented as median (range) or mean ± SD. LND, lymph node dissection; CLND, central lymph node dissection; LLND, lateral lymph node dissection; ETE, extrathyroidal extension; RTx, radiotherapy. Clinicopathologic differences between patients surviving ＜6 months and ≥6 months Table 2 summarizes the clinicopathologic differences between patients surviving more or less than 6 months. In patients surviving ≥6 months, females predominated (P = 0.152) and the median age was younger (56 years vs. 54 years, P = 0.463). All patients in this group underwent total thyroidectomy (P = 0.152). The size of the lesion in patients surviving ≥6 months was always ＜5 cm (P = 0.109), and thesurgery.or.kr Values are presented as median (range) or mean ± SD. ETE, extrathyroidal extension; RTx, radiotherapy. Table 3 . Clinicopathologic differences between patients with lesions ＜5 cm and ≥5 cm there were no cases of lymphatic invasion (P = 0.455).
RESULTS

Clinicopathologic characteristics and demographic findings
However, these results were not statistically significant.
All patients with lesions of ＜5 cm in size underwent total thyroidectomy (P = 0.182), and the operation time was significantly shorter than the operation time in patients with larger lesions (140 minutes vs. 247.5 minutes, P ＜ 0.05). All patients with lesions of ＜5 cm in size were female, whereas all patients with lesions of ≥5 cm in size were male (P = 0.018). No patient with a lesion of ＜5 cm displayed lymphatic invasion (P = 0.200) (Table 3) .
However, these findings were not statistically significant.
DISCUSSION
The aim of this study was to analyze the clinicopathologic characteristics of patients diagnosed with ATC who were expected to undergo curative thyroidectomy preoperatively, with the aim of revealing differences between patients surviving ＜6 months and ≥6 months. The present retrospective analysis of 30 years of experience at a single institution contributes to the understanding of the demographic and clinicopathologic differences between these patient groups. Female predominance, initial presentation with neck mass, and a median age of 55 years were found, similar to the findings of other published reports [1, 11, 14, 15] . The median age of this study was younger than that of a large-scale study among Western patients with a mean age of 71.3 years [7] . Although our analysis involved a very small sample size, the demographic findings are considered to be relatively reliable.
Treatment modalities for ATC include combination therapy with surgical resection for local control, external beam radiotherapy, and chemotherapy. The combination of surgery and radiotherapy is the most effective treatment modality in controlling local disease [16] . Radical resection of ATC is considered to be an important therapy in locally advanced disease [17] . One published report, based on a 30-year single-center experience, found that maximal debulking surgery combined with adjuvant chemotherapy was the best method in patients with ATC [18] , while another study indicated that tumor debulking should be performed before adjuvant therapy. They reported a single center experience of eight patients who underwent potentially curative surgery, and estimated the 2-and 5-year survival rates as 75% and 50%, respectively [19] . The role of surgery as a treatment modality has been unclear; nevertheless, surgery should be considered in the treatment of ATC, especially when treating its relatively less aggressive forms. Multimodal treatment including surgery is ideal for prolonged locoregional control and patient survival [20] .
Although many studies have been performed with various treatment approaches, the survival benefits of these modalities remain unclear [21] . Reported prognostic factors include patient age, tumor size, extent of disease, and treatment modality. However, these factors have been found under heterogeneous combinations of treatment modalities or palliative therapy. Two published reports have concerned Korean patients diagnosed with ATC.
Chang et al. [6] reported difficulties in the treatment of ATC due to its poor prognosis. Kim et al. [22] stated that curative surgery and adjuvant radiotherapy should be applied in selected patients with tumor size ＜5 cm, age ＜55
years, and no distant metastasis at initial presentation.
However, these previous studies included some palliative cases that underwent debulking or incomplete surgery (e.g., biopsy only).
We assessed the usefulness of surgery in patients who were expected to undergo curative surgery preope- For unknown reasons, the incidence of well-differentiated thyroid cancer is increasing [10, 23] , while the incidence of ATC has decreased. Several possible explanations are offered for the decreasing incidence [10] , such as aggressive resection of well-differentiated thyroid malignancy, which eliminates the potential of dedifferentiation [24] , and improved iodine prophylaxis and socioeconomic status [25] . This trend leads to the expectation that future cases of ATC cancer should be detected at earlier stages than in past decades. The present attempt to find prognostic factors in patients with ATC with expected curative thyroidectomy preoperatively can offer one clue for the treatment of ATC.
This study had some limitations. Firstly, the sample size was very small. However, the demographic results echo those of other published studies, making it more likely that these data from a single center are valid. Secondly, there was a possibility of selection bias, because the authors limited the cases to patients who underwent thyroidectomy. To overcome these limitations, because of the thesurgery.or.kr rarity of the disease, a multicenter approach utilizing strict inclusion criteria would be required.
In conclusion, the results of this study suggest that ATC cancer shows a female predominance, initially presents with neck mass, and involves patients with a median age of 55 years. For patients with ATC who expect to undergo curative thyroidectomy preoperatively, surgical treatment should be considered actively when the size of the lesion is ＜5 cm. Total thyroidectomy can be performed easily by an experienced surgeon. Further multicenter clinical analyses are required to establish a standard protocol for the management of early-stage ATC to improve patients' survival.
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